Trinity Biotech Plc Adr stock is traded at $5.38, with a volume of 5,999. It is down -11.89% in the last 24 hours and down -33.06% over the past month. Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
Previous Close:
$6.10
Open:
$5.89
24h Volume:
5,999
Relative Volume:
0.64
Market Cap:
$4.37M
Revenue:
$43.86M
Net Income/Loss:
-$37.43M
P/E Ratio:
-
EPS:
-$2.02
Net Cash Flow:
-$12.50M
1W Performance:
-8.59%
1M Performance:
-33.06%
6M Performance:
-68.81%
1Y Performance:
-78.12%
1-Day Range:
$5.34$6.00
1-Week Range:
$5.34$6.10
52-Week Range:
$5.00$52.50
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS